Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Crestani

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Revue Des Maladies Respiratoires|February 5, 2023
[Adipocytes, adipokines and metabolic alterations in pulmonary fibrosis]K El Husseini, N Poté, M Jaillet, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1994
Interleukin-8 and neutrophils in systemic sclerosis with lung involvementB Crestani, N Seta, E Palazzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosisR Lebtahi, B Crestani, N Belmatoug, et al.
Revue Des Maladies Respiratoires|December 7, 2020
[Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020]C Andrejak, V Cottin, B Crestani, et al.
The European Respiratory Journal|October 21, 2009
Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevanceC Quesnel, L Nardelli, P Piednoir, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1994
Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvementB Crestani, N Seta, M De Bandt, et al.
Respiratory Medicine and Research|August 11, 2020
Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trialT Bejan-Angoulvant, J-Marc Naccache, A Caille, et al.
Revue De Pneumologie Clinique|August 2, 2015
[3rd French day of idiopathic pulmonary fibrosis. September 19, 2014]V Cottin, B Crestani, C Danel, et al.
International Journal of Cancer|January 2, 1991
CA 50 determination in body fluids: can we screen patients at risk for gastric cancer?F Farinati, J Holmgren, F Di Mario, et al.
Thorax|September 30, 2004
Decreased expression of interleukin 13 in human lung emphysemaA Boutten, M Bonay, S Laribe, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Revue Des Maladies Respiratoires|February 5, 2023
[Adipocytes, adipokines and metabolic alterations in pulmonary fibrosis]K El Husseini, N Poté, M Jaillet, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1994
Interleukin-8 and neutrophils in systemic sclerosis with lung involvementB Crestani, N Seta, E Palazzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosisR Lebtahi, B Crestani, N Belmatoug, et al.
Revue Des Maladies Respiratoires|December 7, 2020
[Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020]C Andrejak, V Cottin, B Crestani, et al.
The European Respiratory Journal|October 21, 2009
Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevanceC Quesnel, L Nardelli, P Piednoir, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1994
Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvementB Crestani, N Seta, M De Bandt, et al.
Respiratory Medicine and Research|August 11, 2020
Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trialT Bejan-Angoulvant, J-Marc Naccache, A Caille, et al.
Revue De Pneumologie Clinique|August 2, 2015
[3rd French day of idiopathic pulmonary fibrosis. September 19, 2014]V Cottin, B Crestani, C Danel, et al.
International Journal of Cancer|January 2, 1991
CA 50 determination in body fluids: can we screen patients at risk for gastric cancer?F Farinati, J Holmgren, F Di Mario, et al.
Thorax|September 30, 2004
Decreased expression of interleukin 13 in human lung emphysemaA Boutten, M Bonay, S Laribe, et al.
Pageof 15